Sign for Notice Everyday    Sign Up| Sign In| Link|

Our Sponsors

    Receive Latest News

    Feedburner
    Share Us

    HEALTHCARE TRAINING 2021 - Medical Device Complaints & CAPA

    View: 89

    Website https://www.compliance4all.com/webinar/medical-device-complaints-&-capa-503560LIVE | Edit Freely

    Category HEALTHCARE TRAINING 2021

    Deadline: March 09, 2021 | Date: March 09, 2021

    Venue/Country: Online event, U.S.A

    Updated: 2021-01-15 15:55:59 (GMT+9)

    Call For Papers - CFP

    Overview:

    This webinar will explain the CAPA process from information gathering through MDR and Recall decision making to final CAPA closing.

    Post closing effectiveness evaluation is required and will be explained. Preventative Action is often neglected and will be discussed. Post distribution product monitoring including customer surveys will be explained. Integration of manufacturing non conformaties with the CAPA program will be discussed.

    Why you should Attend: Complaint handling and Corrective and Preventative Action (CAPA) is considered by the FDA to be two of the most important areas to assure medical device safety and efficacy. They are in the top five areas where FDA finds problems during inspections and issues 483's. Medical device developers must understand the complicated Complaint and CAPA process and have a strong CAPA program. A key understanding is striking a balance between too many CAPA's (strangles the system) and too few (problem areas escape fixing).


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.